Investor Relations
Stock Price Information
GNI Group Ltd.
Listed: Tokyo Stock Exchange Growth Market (Ticker: 2160)
| Stock Price | Total No. of Shares | Market Cap |
|---|---|---|
| JPY 3,115 | 50,161,243 | JPY 156.2 Billion |
(As of January 17, 2025 Close)
Gyre Therapeutics, Inc.
Listed: Nasdaq (Ticker: GYRE)
| Stock Price | Total No. of Shares¹ | Market Cap | No. of Shares GNI Owns¹ | Market Cap GNI Owns |
|---|---|---|---|---|
| USD 10.95 | 85,769,526 | USD 939 Million | 72,773,219 | USD 796 Million |
| ー | ー | JPY 145.8 Billion | ー | JPY 123.7 Billion |
(Source: GYRE filings) 1: Including preferred stocks
FX rate:1USD=155.26 JPY (JPY translated based on Mizuho Bank TTM on the same date)
(As of January 17, 2025 Close)
| GNI Ownership | 84.84% |
|---|
Rating Information
| Company | Rating | Target Price | updated on |
|---|---|---|---|
| Ishare Inc. | BUY | 6,300 JPY | 11/15 |
| Jefferies Securities | BUY | 3,700 JPY | 8/29 |
| Mizuho Securities | BUY | 4,000 JPY | 9/12 |
| （Average） | – | 4,666 JPY | – |
- Message
-
Director, Representative Executive Officer, President and CEO
Ying Luo, PhD
